Health Canada has issued a warning against purchasing unauthorized GLP-1 drugs, such as semaglutide found in Ozempic and Wegovy, due to potential health risks from counterfeit products. As demand rises for these weight loss medications, Health Canada has identified retailers selling unauthorized versions, some of which misuse official logos to mislead consumers. The agency emphasizes the importance of buying prescription drugs from licensed pharmacies and checking for proper authorization. Health Canada is actively monitoring the market and collaborating with the Canada Border Services Agency to prevent unauthorized shipments.
